Ftse Mib
33.629,21
-0,32%
DAX
18.001,60
0,54%
S&P 500
5.127,79
1,26%
NASDAQ
16.156,33
1,99%
Bitcoin
62.865,65
-0,04%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Vaxxinity Inc (VAXX) Vaxxinity Inc (VAXX) Notizie

Vaxxinity Inc

VAXX
0,138
0,0338 (32,44%)
04 Mag 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
20/4/202400:53GLOBEVaxxinity Issues Shareholder Letter
19/4/202422:27GLOBEVaxxinity Announces Intention to Voluntarily Delist and..
28/3/202414:23GLOBEVaxxinity to Present Clinical Data at the Annual Academy of..
27/3/202421:41GLOBEVaxxinity Reports Fourth Quarter and Full-Year 2023..
07/3/202416:32GLOBEVaxxinity Announces Positive Target Engagement Data from..
15/2/202422:15EDGAR2Form 8-K - Current report
15/2/202414:00GLOBEVaxxinity’s Cholesterol Vaccine Candidate Successfully..
13/2/202414:00GLOBEVaxxinity to Present Clinical and Preclinical Pipeline Data..
12/2/202423:02EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
12/2/202423:02EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
30/1/202414:00GLOBEVaxxinity Announces Research Collaboration on Active..
18/1/202414:00GLOBEVaxxinity Announces Collaboration on Space Medicine Research..
03/1/202414:00GLOBEVaxxinity to Present at the 2024 J.P. Morgan Healthcare..
01/12/202316:30EDGAR2Form 8-K - Current report
30/11/202323:03EDGAR2Form 144 - Report of proposed sale of securities
30/11/202322:54EDGAR2Form 144 - Report of proposed sale of securities
29/11/202323:13EDGAR2Form 144 - Report of proposed sale of securities
29/11/202323:10EDGAR2Form 144 - Report of proposed sale of securities
21/11/202322:21EDGAR2Form 144 - Report of proposed sale of securities
21/11/202322:20EDGAR2Form 144 - Report of proposed sale of securities
14/11/202300:50GLOBEVaxxinity to Present at Upcoming November Medical and..
08/11/202314:30GLOBEVaxxinity Reports Third Quarter 2023 Financial Results and..
08/11/202313:53EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03/11/202321:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202322:33EDGAR2Form 144 - Report of proposed sale of securities
04/10/202322:24EDGAR2Form 144 - Report of proposed sale of securities
28/9/202322:15EDGAR2Form 8-K - Current report
22/9/202322:16EDGAR2Form 144 - Report of proposed sale of securities
22/9/202322:12EDGAR2Form 144 - Report of proposed sale of securities
29/8/202314:00GLOBEVaxxinity to Present at Upcoming Investor Conferences in..
21/8/202306:15EDGAR2Form EFFECT - Notice of Effectiveness
10/8/202314:00GLOBEVaxxinity Announces Publication of UB-311 Safety,..
09/8/202314:00GLOBEVaxxinity Reports Second Quarter 2023 Financial Results and..
09/8/202313:31EDGAR2Form S-3 - Registration statement under Securities Act of..
09/8/202313:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
27/7/202322:30GLOBEVaxxinity Appoints Peter Powchik, M.D., to Executive Vice..
27/7/202322:04EDGAR2Form 8-K - Current report
17/7/202314:00GLOBEVaxxinity Demonstrates Target Engagement of Toxic..
22/6/202314:00GLOBEVaxxinity Announces UB-312 Successfully Met Primary..
09/5/202314:00GLOBEVaxxinity Reports First Quarter 2023 Financial Results and..
Apertura: 0,1486 Min: 0,1222 Max: 0,1488
Chiusura: 0,1042

La tua Cronologia

NASDAQ
VAXX
Vaxxinity
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network